SOLICITATION NOTICE
B -- Coordination of the Taiwan study centers of the AsiaLymph study
- Notice Date
- 8/25/2010
- Notice Type
- Presolicitation
- NAICS
- 541990
— All Other Professional, Scientific, and Technical Services
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 6120 Executive Blvd., EPS Suite 600, Rockville, Maryland, 20852
- ZIP Code
- 20852
- Solicitation Number
- NCI-100210-TG
- Archive Date
- 9/24/2010
- Point of Contact
- Terry Galloway, Phone: 301-402-4509, Caren N Rasmussen, Phone: (301) 402-4509
- E-Mail Address
-
gallowaytl@mail.nih.gov, cr214i@nih.gov
(gallowaytl@mail.nih.gov, cr214i@nih.gov)
- Small Business Set-Aside
- N/A
- Description
- Contracting Office Address Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 6120 Executive Blvd. EPS Room 6068, Rockville, MD, 20852, UNITED STATES Description The National Cancer Institute (NCI), Division of Cancer Epidemiology and Genetics (DCEG), Occupational and Environmental Epidemiology Branch (OEEB) plans to procure on a sole source basis coordination services for the Taiwan study centers of the AsiaLymph Study from University of Chicago, 5841 S. Maryland Ave., MC 2007, Rm. N101E, Chicago, Illinois 60637. The services herein are being procured in accordance with the simplified acquisition procedures as authorized by FAR Part 13.106-1 (b)(1). The North American Industry Classification System code is 541990 and the business size standard is $7.0 Million. Only one award will be made as a result of this solicitation. This will be awarded as a firm fixed price type contract. Period of Performance shall be for twelve (12) months from date of award. The contribution of environmental, occupational and genetic factors to lymphoma has generated a series of novel, cutting edge findings in studies of Caucasians. However, the ability to follow-up, confirm and extend these observations has become limited by the low prevalence and limited range of several important chemical exposures and the high to complete linkage disequilibrium between key candidate genetic loci in Western populations. To optimize the ability to build on and clarify these findings, it is necessary to investigate populations that differ from Caucasians in both exposure patterns and underlying genetic structure. Thus, the NCI is initiating a hospital-based case-control study of lymphoma in Eastern Asia (i.e., AsiaLymph) of 3,000 cases and 3,000 controls. The major postulated risk factors for evaluation in this study are chemical exposures (i.e., organochlorines, trichloroethylene and benzene), genetic susceptibility, and infectious agents. AsiaLymph should confirm and extend previous findings, and yield novel insights into the causes of lymphoma in both Asia and the West. The National Cancer Institute hospital-based case-control study of lymphoma (AsiaLymph) will be conducted in Taiwan, Hong Kong, and mainland China. The contractor shall provide a study coordinator that is needed to manage all aspects of the AsiaLymph study for the participating hospitals in Taiwan, which are included in the Chang Gung Memorial Hospital System and the Tzu Chi General Hospital System. University of Chicago is on the forefront of this field and has previously collaborated on epidemiological initiatives with the Chang Gung Memorial Hospital System and the Tzu Chi General Hospital System. Dr. Brian Chiu from the University of Chicago has efficiently and productively worked with clinicians, pathologists, epidemiologists, and hospital administrators at these locations. As such, the University of Chicago as represented by Dr. Chiu is the only known source to fulfill the tasks of this procurement. This notice is not a request for competitive quotation. However, if any interested party believes it can meet the above requirement, it may submit a statement of capabilities. The statement of capabilities and any other information furnished must be in writing and must contain material in sufficient detail to allow NCI to determine if the party can perform the requirement. Capability statements must be received in the contracting office by 11:00 AM EST, on September 9, 2010. For further information, please contact Terry Galloway, Contract Specialist via electronic mail at gallowaytl@mail.nih.gov. A determination by the Government not to compete this proposed requirement based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. No collect calls will be accepted. No faxed or emailed capability statements will be accepted. In order to receive an award, contractors must be registered and have valid certification in the Central Contractor Registration (CCR) and the Online Representations and Certifications Applications (ORCA). Reference: NCI-100210-TG on all correspondence.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/RCB/NCI-100210-TG/listing.html)
- Record
- SN02254865-W 20100827/100825235746-b1a8f4c9e9e4e378c54fe28f72b1c3ef (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |